16
Omalizumab (Anti-IgE) Therapy in The Asthma–COPD Overlap Syndrome (ACOS) ARZU DIDEM YALCIN

Eaaci ppt-acos

Embed Size (px)

Citation preview

Page 1: Eaaci  ppt-acos

Omalizumab (Anti-IgE)  Therapy in The Asthma–COPD Overlap

Syndrome (ACOS)ARZU DIDEM YALCIN

Page 2: Eaaci  ppt-acos
Page 3: Eaaci  ppt-acos
Page 4: Eaaci  ppt-acos

22.

Page 5: Eaaci  ppt-acos
Page 6: Eaaci  ppt-acos
Page 7: Eaaci  ppt-acos
Page 8: Eaaci  ppt-acos

23. Circulating Adipokine chemerin, irisin and IL-1β Levels were Increased in Severe

Persistent Allergic Asthma Patients

Sunum No: SS-012Sunum Tarihi: 7 Nisan 2016 Perşembe

Sunum Saati: 07:40 - 07:50Salon Adı: Salon 5

Page 9: Eaaci  ppt-acos
Page 10: Eaaci  ppt-acos
Page 11: Eaaci  ppt-acos
Page 12: Eaaci  ppt-acos
Page 13: Eaaci  ppt-acos
Page 14: Eaaci  ppt-acos
Page 15: Eaaci  ppt-acos